Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01WHI
|
||||
Former ID |
DIB020151
|
||||
Drug Name |
L023103
|
||||
Synonyms |
L 023103; L-023103
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [539394] | ||
Structure |
Download2D MOL |
||||
Formula |
C30H33ClN6O5S
|
||||
InChI |
InChI=1S/C30H33ClN6O5S/c1-36(2)19-5-18-32-27(38)17-10-21-8-15-24(16-9-21)43(41,42)37(23-13-11-22(31)12-14-23)20-28(39)34-35-29-25-6-3-4-7-26(25)33-30(29)40/h3-4,6-9,11-16H,5,10,17-20H2,1-2H3,(H,32,38)(H,34,39)(H,33,35,40)
|
||||
InChIKey |
BUKWNCANUKACAQ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Vasopressin V1a receptor | Target Info | Antagonist | [527891] | |
Oxytocin receptor | Target Info | Antagonist | [527891] | ||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
PANTHER Pathway | Oxytocin receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.